EGFR and non-small cell lung carcinoma: Rekhtman et al. reported that “pure” squamous cell lung cancer, verified by immunohistochemistry as Np63 (+)/TTF-1(-), lacked EGFR mutations [17], thus leaving lung adenocarcinoma as the major candidate for EGFR screening in NSCLC.